IDIBELL on the media
Coffee could have a protective effect against endometrial cancer
An epidemiological study co-led by IDIBELL, the Catalan Institute of Oncology (ICO), and Harvard University (Boston, USA) observed that coffee consumption could have a protective effect against the risk of suffering endometrial cancer.
Organoids from the research group of Dr. Sandra Acosta exhibited at the CCCB exposition Cervells(s)
The Cervell(s) exhibition delves into this organ from different artistic, historical, and scientific perspectives, including the results of real projects such as the case of Dr. Sandra Acosta.
Patients with Idiopathic Pulmonary Fibrosis who follow a Mediterranean diet have fewer gastrointestinal adverse effects
Doctors Maria Molina and Vanesa Vicens Zygmunt presented the results of the MADIET clinical trial at the International Fibrosis Congress. The clinical trial was coordinated by the Pulmonology research group from IDIBELL and the Bellvitge University Hospital (HUB) with the participation of hospitals from six European countries.
It starts a project to create a collaborative network for the generation of stem cells compatible with a high percentage of the population
The project aims to create a collaborative network for induced pluripotency stem cells (iPS) homozygous for the most frequent HLA haplotypes generation.
Great success at the Sinergia 2022 Open Day
This Saturday, the Bellvitge Campus opened its doors to bring the research of one of the most important biomedical centers in the country closer to the public. With activities such as guided tours, talks, escape rooms, and gymkhanas the event had a great attendance success.
A new study confirms that deep brain stimulation halves symptoms in severe OCD
This is the second largest sample of patients in the world, treated and followed up by a multidisciplinary team at Bellvitge since 2007. The results suggest that, in addition to reducing obsessive symptoms, the treatment reduces anxiety and depression in these patients.
Researchers validate a microRNA as a biomarker for the diagnosis of azoospermia
A new study confirms the clinical utility of a test based on the quantification of miR-31-5p microRNA levels in semen as a non-invasive biomarker to distinguish the origin of azoospermia
IDIBELL organized a meeting of breast cancer solidarity donors and associations
Yesterday, the breast cancer research team received associations and individuals who, thanks to their donations, have promoted research.
The fourth edition of Sinergia arrives, the festival of health research and innovation of L’Hospitalet
Throughout the week of October 3rd to 8th, gymkhanas, talks, visits, and many other activities will bring science from the Bellvitge Campus closer to the public.
Success of the second symposium of the Oncobell research program
This Monday and Tuesday, September 19 and 20, the second Oncobell Symposium was held in the auditorium of the Bellvitge University Hospital. Under the slogan “building bridges between science, medicine and people” the congress is a forum to discuss the latest advances in basic and clinical research with top-level cancer professionals